Genetic counselors' experience with cell-free fetal DNA testing as a prenatal screening option for aneuploidy

Journal of Genetic Counseling

Volumn 23, Issue 3, 2014, Pages 377-400

  Horsting, Julie M H ^a   Dlouhy, Stephen R ^a   Hanson, Katelyn ^a   Quaid, Kimberly ^a   Bai, Shaochun ^a   Hines, Karrie A ^b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY HEALTH   (United States)

Author keywords

Aneuploidy; Cell free fetal DNA; Genetic counseling; Non invasive prenatal testing; Prenatal; Screening

Indexed keywords

DNA;

ADULT; ANEUPLOIDY; CELL FREE SYSTEM; FEMALE; FETUS; GENETIC COUNSELING; HUMAN; HUMAN CHROMOSOME; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES;

ADULT; ANEUPLOIDY; CELL-FREE SYSTEM; CHROMOSOMES, HUMAN; DNA; FEMALE; FETUS; GENETIC COUNSELING; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84901829603     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-013-9673-4     Document Type: Article

References (24)

1. American College of Obstetricians and Gynecologists. (2012). Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545. Obstetrics and Gynecology, 120, 1532-1534.
2. Benn, P.; Cuckle, H.; & Pergament, E. (2013). Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound in Obstetrics and Gynecology. doi: 10.1002/uog.12513.
3. Bensend, T. A.; Veach, P. M.; & Niendorf, K. B. (2013). What's the harm? Genetic counselor perceptions of adverse effects of genetics service provision by non-genetics professionals. Journal of Genetic Counseling. doi: 10.1007/s10897-013-9605-3.
4. Bianchi, D. W.; Platt, L. D.; Goldberg, J. D.; Abuhamad, A. Z.; Sehnert, A. J.; & Rava, R. P. (2012). Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. MatErnal Blood Is Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Obstetrics and Gynecology, 119, 890-901.
5. Chen, E. Z.; Chiu, R. W.; SUN, H.; Akolekar, R.; Chan, K. C.; Leung, T. Y.; et al. (2011). Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS ONE, 6, e21791.
6. Chiu, R. W.; Akolekar, R.; Zheng, Y. W.; LeungTY, S. H.; Chan, K. C.; et al. (2011). Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validation study. BMJ, 342, c7401.
7. Devers, P. L.; Cronister, A.; Ormond, K. E.; Facio, F.; Brasington, C. K.; & Flodman, P. (2012). Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the national society of genetic counselors. Journal of Genetic Counseling. doi: 10.1007/s10897-012-9564-0.
8. Ehrich, M.; Deciu, C.; Zwiefelhofer, T.; Tynan, J. A.; Cagasan, L.; Tim, R.; et al. (2011). Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. American Journal of Obstetrics and Gynecology, 204, 205.e1-11.
9. Hall, A. L.; Drendel, H. M.; Verbrugge, J. L.; Reese, A. M.; Schumacher, K. L.; Griffith, C. B.; et al. (2013). Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism. Genetics in Medicine. doi: 10.1038/gim.2013.26.
10. Lo, Y. M.; Corbetta, N.; Chamberlain, P. F.; Rai, V.; Sargent, I. L.; Redman, C. W.; et al. (1997). Presence of fetal DNA in maternal plasma and serum. Lancet, 350, 485-487. (Pubitemid 27343304)
11. McPherson, E.; Thomas, G. D.; Manlick, C.; Zaleski, C. A.; Reynolds, K. K.; Rasmussen, K.; et al. (2011). Extreme values of maternal serum analytes in second trimester screening: Looking beyond trisomy and NTD's. Journal of Genetic Counseling, 20, 396-403.
12. Mennuti, M. T.; Cherry, A. M.; Morrissette, J. J.; & Dugoff, L. (2013). Is it time to sound an alarm about false positive cell-free DNA testing for fetal aneuploidy? American Journal of Obstetrics and Gynecology. doi: 10.1016/j.ajog.2013.03.027.
13. Musci, T. J.; Fairbrother, G.; Batey, A.; Bruursema, J.; Struble, C.; & Song, K. (2013). Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice. Prenatal Diagnosis, 33(5), 424-428.
14. Norton, M. E.; Brar, H.; Meiss, J.; Karimi, A.; Laurent, L. C.; Caughey, A. B.; et al. (2012). Non-Invasive Chromosomal Evaluation (NICE) study: results of a multicenter, prospective, cohort study for detection of fetal trisomy 18. American Journal of Obstetrics and Gynecology, 207(2), 137.e1-137.e8.
15. Norton, M. E.; Rose, N. C.; & Benn, P. (2013). Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint. Obstetrics and Gynecology, 121(4), 847-850.
16. Palomaki, G. E.; Kloza, E. M.; Lambert-Messerlian, G. M.; Haddow, J. E.; Neveux, L. M.; Ehrich, M.; et al. (2011). DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genetics in Medicine, 13, 913-920.
17. Palomaki, G. E.; Deciu, C.; Kloza, E. M.; Lambert-Messerlian, G. M.; Haddow, J. E.; Neveux, L. M.; et al. (2012). DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genetics in Medicine, 14, 296-305.
18. Patton, M. Q. (2001). Qualitative evaluation and research methods. Thousand Oaks: Sage.
19. Sayres, L.; Allyse, M.; Norton, M.; & Cho, M. (2011). Cell-free fetal DNA testing: A pilot study of obstetric healthcare provider attitudes towards clinical implementation. Prenatal Diagnosis, 31(11), 1070-1076.
20. Sparks, A. B.; Wang, E. T.; Struble, C. A.; Barrett, W.; Stolowski, R.; McBride, C.; et al. (2012). Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenatal Diagnosis, 32, 3-9.
21. Taylor, J.B.; Chock, V.Y.; Hudgins, L. (2013). NIPT in a clinical setting: an analysis of uptake in the first months of clinical availability. Journal of Genetic Counseling [Epub ahead of print].
22. Vahanian, S.A.; Baraa, A.M.; Yeh, C.; Chavez, M.R.; Kinzler, W.L.; Vintzileos, A.M. (2013). Patient acceptance of non-invasive testing for fetal aneuploidy via cell-free fetal DNA. Journal of Maternal-Fetal and Neonatal Medicine. PMID: 23687914.
23. Wapner, R. J.; Martin, C. L.; Levy, B.; Ballif, B. C.; Eng, C. M.; Zachary, J. M.; et al. (2012). Chromosomal microarray versus karyotyping for prenatal diagnosis. The New England Journal of Medicine, 367(23), 2175-2184.
24. Wright, C. F.; & Burton, H. (2009). The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Human Reproduction Update, 15(1), 139-151.